相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis
Behnam Khalilian et al.
JOURNAL OF MOLECULAR HISTOLOGY (2021)
Role of oxidative stress in depression
Shvetank Bhatt et al.
DRUG DISCOVERY TODAY (2020)
Biotin, coenzyme Q10, and their combination ameliorate aluminium chloride-induced Alzheimer's disease via attenuating neuroinflammation and improving brain insulin signaling
Hala Attia et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
Elisabetta Zucchi et al.
MOLECULAR NEURODEGENERATION (2020)
Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease
L. Holper et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Coenzyme Q10 Alleviated Behavioral Dysfunction and Bioenergetic Function in an Animal Model of Depression
Sina Andalib et al.
NEUROCHEMICAL RESEARCH (2019)
Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer's disease
Hamidreza Komaki et al.
BRAIN RESEARCH BULLETIN (2019)
Influence of adjuvant Coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode
Leila Jahangard et al.
MOLECULAR BIOLOGY REPORTS (2019)
Mitochondrial Dysfunction and Multiple Sclerosis
Isabella Peixoto de Barcelos et al.
BIOLOGY-BASEL (2019)
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-beta 1a-treated multiple sclerosis
Marcello Moccia et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease
Haitao Yu et al.
ARCHIVES OF TOXICOLOGY (2018)
Sex-dependent co-occurrence of hypoxia and β-amyloid plaques in hippocampus and entorhinal cortex is reversed by long-term treatment with ubiquinol and ascorbic acid in the 3 x Tg-AD mouse model of Alzheimer's disease
Javier Frontinan-Rubio et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders
Elham Mousavinejad et al.
PSYCHIATRY RESEARCH (2018)
The relation between obesity and depressed mood in a multi-ethnic population. The HELIUS study
Deborah Gibson-Smith et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2018)
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Josh Allen et al.
FRONTIERS IN NEUROSCIENCE (2018)
Genetics Factors in Major Depression Disease
Maria Shadrina et al.
FRONTIERS IN PSYCHIATRY (2018)
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Mojtaba Golpich et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats
Sally A. Abuelezz et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease
Ming Ying et al.
MOLECULAR NEUROBIOLOGY (2017)
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
Andrew McGarry et al.
NEUROLOGY (2017)
Metabolic Dysfunction and Oxidative Stress in Epilepsy
Jennifer N. Pearson-Smith et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
P. Steullet et al.
MOLECULAR PSYCHIATRY (2017)
Incidence and Course of Depression in Patients with Alzheimer's Disease
Seung-Ho Ryu et al.
PSYCHIATRY INVESTIGATION (2017)
Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy
Hooi Ling Teoh et al.
NEURAL PLASTICITY (2017)
Evaluation of Coenzyme Q as an Antioxidant Strategy for Alzheimer's Disease
Teri L. Wadsworth et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Why is depression more common among women than among men?
Christine Kuehner
LANCET PSYCHIATRY (2017)
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial
Meisam Sanoobar et al.
NUTRITIONAL NEUROSCIENCE (2016)
Mitochondrial Dysfunction in Depression
Yashika Bansal et al.
CURRENT NEUROPHARMACOLOGY (2016)
Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression
John N. Constantino et al.
LANCET NEUROLOGY (2016)
Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: A review
Seyed Soheil Saeedi Saravi et al.
LIFE SCIENCES (2016)
Neuroprotective mechanism of Coenzyme Q10 (CoQ10) against PTZ induced kindling and associated cognitive dysfunction: Possible role of microglia inhibition
Manveen Bhardwaj et al.
PHARMACOLOGICAL REPORTS (2016)
Protein undernutrition during development and oxidative impairment in the central nervous system (CNS): potential factors in the occurrence of metabolic syndrome and CNS disease
D. J. S. Ferreira et al.
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (2016)
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Nataliia Bakunina et al.
IMMUNOLOGY (2015)
PATHOPHYSIOLOGY OF DEPRESSION: DO WE HAVE ANY SOLID EVIDENCE OF INTEREST TO CLINICIANS?
GREGOR HASLER
World Psychiatry (2015)
Selected biomarkers as predictive tools in testing efficacy of melatonin and coenzyme Q on propionic acid - induced neurotoxicity in rodent model of autism
Mashael Al-Ghamdi et al.
BMC NEUROSCIENCE (2014)
The effects of coenzyme Q10 on seizures in mice: The involvement of nitric oxide
Elahe Sattarinezhad et al.
EPILEPSY & BEHAVIOR (2014)
Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of EDP-17 transgenic mice
Elizabeth S. Yamada et al.
EXPERIMENTAL NEUROLOGY (2014)
Clinical applications of coenzyme Q10
Juan Garrido-Maraver et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
Dimitris N. Xanthos et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Ubiquinol Improves Symptoms in Children with Autism (Publication with Expression of Concern. See vol. 2020, 2020)
Anna Gvozdjakova et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia?
Mario D. Cordero et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development
Andrew A. Nierenberg et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis
Meisam Sanoobar et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Coenzyme Q10 Ameliorates Neurodegeneration, Mossy Fiber Sprouting, and Oxidative Stress in Intrahippocampal Kainate Model of Temporal Lobe Epilepsy in Rat
Tourandokht Baluchnejadmojarad et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Mitochondrial abnormalities in temporal lobe of autistic brain
Guomei Tang et al.
NEUROBIOLOGY OF DISEASE (2013)
Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats
Sawsan Aboul-Fotouh
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Antioxidants for Alzheimer Disease A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures
Douglas R. Galasko et al.
ARCHIVES OF NEUROLOGY (2012)
Epilepsy across the spectrum: Promoting health and understanding. A summary of the Institute of Medicine report
Mary Jane England et al.
EPILEPSY & BEHAVIOR (2012)
AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
Chee-Hoe Ng et al.
JOURNAL OF NEUROSCIENCE (2012)
Mitochondrial dysfunction in epilepsy
Jaroslava Folbergrova et al.
MITOCHONDRION (2012)
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
D. A. Rossignol et al.
MOLECULAR PSYCHIATRY (2012)
Oxidative Stress Correlates with Headache Symptoms in Fibromyalgia: Coenzyme Q10 Effect on Clinical Improvement
Mario D. Cordero et al.
PLOS ONE (2012)
Mitochondrial dysfunction in ALS
Mauro Cozzolino et al.
PROGRESS IN NEUROBIOLOGY (2012)
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Kathleen R. Merikangas et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
B cells in multiple sclerosis: connecting the dots
H-Christian von Buedingen et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress
Mona K. Tawfik
EPILEPSY & BEHAVIOR (2011)
Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimer's Disease
Magali Dumont et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
M. Berk et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
The Heritability of Amyotrophic Lateral Sclerosis in a Clinically Ascertained United States Research Registry
Thomas S. Wingo et al.
PLOS ONE (2011)
Mitochondrial protein quality control during biogenesis and aging
Brooke M. Baker et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar Disorder
Ana C. Andreazza et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Complex III-dependent superoxide production of brain mitochondria contributes to seizure-related ROS formation
Dominika Malinska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
M. Mancuso et al.
CURRENT DRUG TARGETS (2010)
Role of coenzyme Q10 as an antioxidant and bioenergizer in periodontal diseases
Shobha Prakash et al.
INDIAN JOURNAL OF PHARMACOLOGY (2010)
Fever Plus Mitochondrial Disease Could Be Risk Factors for Autistic Regression
John Shoffner et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Safety and Tolerability of High-Dosage Coenzyme Q10 in Huntington's Disease and Healthy Subjects
H. Christopher Hyson et al.
MOVEMENT DISORDERS (2010)
The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?
Junghee Lee et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III
Petra Kaufmann et al.
ANNALS OF NEUROLOGY (2009)
Mitochondrial changes within axons in multiple sclerosis
Don J. Mahad et al.
BRAIN (2009)
Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL)
Anna Rita Fetoni et al.
BRAIN RESEARCH (2009)
Combination therapy with Coenzyme Q(10) and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's Diseases
Lichuan Yang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics
Christopher A. Ross et al.
PARKINSONISM & RELATED DISORDERS (2009)
Diet supplement CoQ(10) delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: An in vivo volume MRI study
Geng Li et al.
BIOFACTORS (2008)
Human CoQ(10) deficiencies
C. M. Quinzii et al.
BIOFACTORS (2008)
Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation
Xifei Yang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Coenzyme Q10 An Independent Predictor of Mortality in Chronic Heart Failure
Sarah L. Molyneux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies
D. S. Khurana et al.
NEUROPEDIATRICS (2008)
Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism
Carine Cleren et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial
Nicholas A. Di Prospero et al.
LANCET NEUROLOGY (2007)
Bioenergetic and antioxidant properties of coenzyme Q10:: Recent developments
Gian Paolo Littarru et al.
MOLECULAR BIOTECHNOLOGY (2007)
Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication
Kathleen R. Merikangas et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Coenzyme Q10 and exercise training in chronic heart failure
Romualdo Belardinelli et al.
EUROPEAN HEART JOURNAL (2006)
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Karen M. Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Preparing for preventive clinical trials - The predict-HD study
JS Paulsen et al.
ARCHIVES OF NEUROLOGY (2006)
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled
Paula M. Keeney et al.
JOURNAL OF NEUROSCIENCE (2006)
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
HN Bhagavan et al.
FREE RADICAL RESEARCH (2006)
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
EC Stack et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease
HJ Choi et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS
KL Ferrante et al.
NEUROLOGY (2005)
CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats
PI Moreira et al.
EXPERIMENTAL NEUROLOGY (2005)
Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10
M Somayajulu et al.
NEUROBIOLOGY OF DISEASE (2005)
Antioxidant treatment of patients with Friedreich ataxia - Four-year follow-up
PE Hart et al.
ARCHIVES OF NEUROLOGY (2005)
Mitochondrial dysfunction in autism spectrum disorders:: a population-based study
G Oliveira et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2005)
An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients
M Sohmiya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
Y Gilgun-Sherki et al.
JOURNAL OF NEUROLOGY (2004)
Coenzyme Q10 in neurodegenerative diseases
CW Shults
CURRENT MEDICINAL CHEMISTRY (2003)
The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic
MWIM Horstink et al.
ARCHIVES OF NEUROLOGY (2003)
Mechanisms of disease: Mitochondrial respiratory-chain diseases
S DiMauro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease
T Müller et al.
NEUROSCIENCE LETTERS (2003)
Effects of coenzyme Q10 in early Parkinson disease -: Evidence of slowing of the functional decline
CW Shults et al.
ARCHIVES OF NEUROLOGY (2002)
Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis
FM Menzies et al.
BRAIN (2002)
Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay:: HEADD syndrome
JJ Filiano et al.
JOURNAL OF CHILD NEUROLOGY (2002)
Mitochondrial involvement in amyotrophic lateral sclerosis
FM Menzies et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Therapeutic effects of coenzyme Q(10) and remacemide in transgenic mouse models of Huntington's disease
RJ Ferrante et al.
JOURNAL OF NEUROSCIENCE (2002)
Biochemical functions of coenzyme Q10
FL Crane
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2001)
Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain
JLM Madrigal et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis
FM Lu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Regulation of ubiquinone metabolism
G Dallner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Psychiatric morbidity, service use, and need for care in the general population: Results of the Netherlands Mental Health Survey and Incidence Study
RV Bijl et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Serum levels of coenzyme Q10 in patients with multiple sclerosis
F de Bustos et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Serum levels of coenzyme Q(10) in patients with amyotrophic lateral sclerosis
JA Molina et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Neurologic presentations of mitochondrial disorders
A Nissenkorn et al.
JOURNAL OF CHILD NEUROLOGY (2000)
分享论文
